The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Regulation of Ferroptotic Cancer Cell Death by GPX4
Open accessAbstract
Ferroptosis is a form of nonapoptotic cell death for which key regulators remain unknown. We sought a common mediator for the lethality of 12 ferroptosis-inducing small molecules. We used targeted metabolomic profiling to discover that depletion of glutathione causes inactivation of glutathione peroxidases (GPXs) in response to one class of compounds and a chemoproteomics strategy to discover that GPX4 is directly inhibited by a second class of compounds. GPX4 overexpression and knockdown modulated the lethality of 12 ferroptosis inducers, but not of 11 compounds with other lethal mechanisms. In addition, two representative ferroptosis inducers prevented tumor growth in xenograft mouse tumor models. Sensitivity profiling in 177 cancer cell lines revealed that diffuse large B cell lymphomas and renal cell carcinomas are particularly susceptible to GPX4-regulated ferroptosis. Thus, GPX4 is an essential regulator of ferroptotic cancer cell death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the reduced glutathione (GSH)-dependent enzyme glutathione peroxidase 4 (GPX4)—which is directly targeted by RSL3—has emerged as the main endogenous inhibitor of ferroptosis by virtue of its ability to limit lipid peroxidation by catalyzing the GSH-dependent reduction of lipid hydroperoxides to lipid alcohols [547–550].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“erastin triggers ferroptosis by (indirectly) affecting the catalytic cycle of GPX4 via a mechanism that involves the inhibition of the cystine/glutamate antiporter system xc− and consequent decrease in intracellular cysteine (which derives from cystine reduction in the cytoplasm) and GSH (which is synthesized from cysteine) [539, 548, 549, 551].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“the ferroptosis-inhibiting effect of iron depletion by either chelators [539, 543, 548] or phosphorylase kinase catalytic subunit gamma 2 (PHKG2) knockdown [566]”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [548]
In the citing paper
“Among these genes, we identified known regulators of apoptosis, such as TP53, IKBIP, and factors specifically of neuronal survival, such as XIAP17–20, GDPGP121 and MAP3K123,22–24, as well as genes not previously implicated in neuronal survival, such as IGF2BP1 and IGF2BP3.”
From Genome-wide CRISPRi/a screens in human neurons link lysosomal failure to ferroptosis (2021) · cites this paper as [19]
In the citing paper
“Inhibitors of this transporter have been found to deplete intracellular glutathione in cancer cells, resulting in iron-dependent accumulation of ROS and a form of cell death termed ferroptosis (Dixon et al., 2012; Dixon et al., 2014; Yang et al., 2014).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Yang et al., 2014
In the citing paper
“Moreover, glutathione is not depleted during RSL3-induced cell death [24], supporting the presence of an alternative ferroptosis-initiating mechanism for RSL3.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Analysis of mass spectrometry-based proteomic data from an affinity pulldown experiment ranked GPX4 (glutathione peroxidase 4, PHGPx) as the top protein target for (1S,3R)-RSL3 [24]; western blotting further confirmed binding between (1S,3R)-RSL3 and GPX4.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Glutathione depletion causes loss of cellular antioxidant capacity, as well as inhibition of glutathione-dependent enzymes, such as glutathione peroxidases [24, 25].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Moreover, knockdown of GPX4 expression generates lipid ROS and induces ferroptosis, supporting the hypothesis that (1S, 3R)-RSL3 induces ferroptosis through inhibition of GPX4 [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“This glutathione depletion is sufficient for erastin-dependent cell death, as glutathione depletion by another reagent, buthionine sulfoxamine (BSO), also initiated ferroptosis [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Cell lysates prepared from (1S, 3R)-RSL3-treated cells could not reduce phosphatidylcholine hydroperoxides into the corresponding alcohols, demonstrating that RSL3 inhibits GPX4 enzyme activity [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“The screening assay in which erastin and RSL3 were identified later revealed ten additional compounds that induce ferroptosis [24, 26]. All but one compound (DPI2) inhibited GPX4 directly, similar to RSL3. In contrast, DPI2 depleted GSH, like erastin [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Overexpression of GPX4 suppressed cell death induced by these compounds [24], but not other lethal agents, indicating that GPX4 is a specific and robust central regulator of ferroptotic cell death, akin to BCL-2 in apoptosis.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Indeed, a metabolite profiling assay revealed that glutathione was the most decreased cellular metabolite during erastin-induced ferroptosis [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Although erastin displayed selective lethality in engineered cells overexpressing HRASG12V , there was no consistent difference in erastin sensitivity between wild-type and mutated RAS cells.”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Tubular cells in the kidney are also particularly susceptible to ferroptosis induction by Gpx4 deletion in vivo [15], which is intriguing in light of the enhanced sensitivity of renal cell carcinoma cell lines in culture to erastin [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“Moreover, RCC was found to be particularly susceptible to erastin-induced ferroptosis compared to other tissues in the NCI-60 panel, a panel of cancer cell lines derived from eight different tissues [24].”
From Ferroptosis: Death by Lipid Peroxidation (2016) · cites this paper as [24]
In the citing paper
“In addition, the depletion of GPX4 can promote the accumulation of lipid peroxide and lipid free radicals, causing ferroptosis (Yang et al., 2014).”
From MiR-378a-3p/ SLC7A11 regulate ferroptosis in nerve injury induced by lead exposure (2022) · cites this paper as Yang et al., 2014
In the citing paper
“Lipid peroxidation is an important characteristic of ferroptosis and is strongly regulated by GPX4 and GSH (Chen et al., 2015;Yang et al., 2014).”
From MiR-378a-3p/ SLC7A11 regulate ferroptosis in nerve injury induced by lead exposure (2022) · cites this paper as Yang et al., 2014
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.03.042 · Cited by 18,691
Self-citationChemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury
Degterev, A., Huang, Z., Boyce, M., Li, Y., Jagtap, P., Mizushima, N., Cuny, G. D., Mitchison, T. J., Moskowitz, M. A., & Yuan, J. (2005) · Nature Chemical Biology · doi:10.1038/nchembio711 · Cited by 3,068
Wendel, A. (1981) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(81)77046-0 · Cited by 3,032
Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis
Menendez, J. A., & Lupu, R. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2222 · Cited by 2,941
The NCI60 human tumour cell line anticancer drug screen
Shoemaker, R. H. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1951 · Cited by 2,673
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,504
Galluzzi, L., Vitale, I., Abrams, J. M., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., Dawson, T. M., Dawson, V. L., El-Deiry, W. S., Fulda, S., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.96 · Cited by 2,421
Brigelius-Flohé, R., & Maiorino, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.11.020 · Cited by 1,904
Yang, W. S., & Stockwell, B. R. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.02.010 · Cited by 1,876
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 601–700 of 1,027
RETRACTED: Ferroptosis is governed by differential regulation of transcription in liver cancer
Zhang, X., Du, L., Qiao, Y., Zhang, X., Zheng, W., Wu, Q., Chen, Y., Zhu, G., Liu, Y., Bian, Z., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101211 · Cited by 188
RetractedYoussef, L. A., Rebbaa, A., Pampou, S., Weisberg, S. P., Stockwell, B. R., Hod, E. A., & Spitalnik, S. L. (2018) · Blood · doi:10.1182/blood-2017-12-822619 · Cited by 186
Self-citationTargeting ferroptosis protects against experimental (multi)organ dysfunction and death
Van Coillie, S., Van San, E., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., Choi, S. M., Roelandt, R., Dumitrascu, C., Lamberts, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28718-6 · Cited by 186
Anticancer Activity of Artemisinin and its Derivatives
Slezáková, S., & Kučerová, J. (2017) · Anticancer Research · doi:10.21873/anticanres.12046 · Cited by 186
Takahashi, N., Cho, P., Selfors, L. M., Kuiken, H. J., Kaul, R., Fujiwara, T., Harris, I. S., Zhang, T., Gygi, S. P., & Brugge, J. S. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.10.010 · Cited by 187
Yang, J., Ma, S., Xu, R. F., Wei, Y., Zhang, J., Zuo, T., Wang, Z., Deng, H., Yang, N., & Shen, Q. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.04.013 · Cited by 186
Qiongyue, Z., Xin, Y., Meng, P., Mi, S., Yanlin, W., Li, X., & Xuemin, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857067 · Cited by 188
Chaudhary, N., Choudhary, B. S., Shah, S. G., Khapare, N., Dwivedi, N., Gaikwad, A., Joshi, N., Raichanna, J., Basu, S., Gurjar, M., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33711 · Cited by 185
Autophagy and Ferroptosis—What Is the Connection?
Kang, R., & Tang, D. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0139-5 · Cited by 186
Glutathione-mediated nanomedicines for cancer diagnosis and therapy
Ding, Y., Dai, Y., Wu, M., & Li, L. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2021.128880 · Cited by 186
Ma, L., Zhang, X., Yu, K., Xu, X., Chen, T., Shi, Y. Y., Wang, Y., Qiu, S., Guo, S., Cui, J., et al. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.023 · Cited by 184
Zhou, C., Yu, T., Zhu, R., Lu, J., Ouyang, X., Zhang, Z., Chen, Q., Li, J., Cui, J., Jiang, F., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.77979 · Cited by 186
Activation of Glutathione Peroxidase 4 as a Novel Anti-inflammatory Strategy
Li, C., Deng, X., Xie, X., Liu, Y., Friedmann Angeli, J. P., & Lai, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01120 · Cited by 183
Yao, X., Yang, P., Jin, Z., Jiang, Q., Guo, R., Xie, R., He, Q., & Yang, W. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.01.026 · Cited by 183
Self-citationMishima, E., Sato, E., Ito, J., Yamada, K., Suzuki, C., Oikawa, Y., Matsuhashi, T., Kikuchi, K., Toyohara, T., Suzuki, T., et al. (2019) · Journal of the American Society of Nephrology · doi:10.1681/asn.2019060570 · Cited by 183
Fan, B., Pang, Y., Li, W., Zhao, C.-X., Zhang, Y., Wang, X., Ning, G., Kong, X., Liu, C., Yao, X. X., et al. (2020) · Neural Regeneration Research · doi:10.4103/1673-5374.293157 · Cited by 186
Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells
Saito, R. D. F., Andrade, L. N. D. S., Bustos, S. O., & Chammas, R. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.768606 · Cited by 190
Creatine kinase B suppresses ferroptosis by phosphorylating GPX4 through a moonlighting function
Wu, K., Yan, M., Liu, T., Wang, Z., Duan, Y., Xia, Y., Ji, G., Shen, Y., Wang, L., Li, L., et al. (2023) · Nature Cell Biology · doi:10.1038/s41556-023-01133-9 · Cited by 189
APR-246 induces early cell death by ferroptosis in acute myeloid leukemia
Birsen, R., Larrue, C., Decroocq, J., Johnson, N., Guiraud, N., Gotanegre, M., Cantero-Aguilar, L., Grignano, E., Huynh, T., Fontenay, M., et al. (2021) · Haematologica · doi:10.3324/haematol.2020.259531 · Cited by 182
Glutathione peroxidase 4 (Gpx4) and ferroptosis: what's so special about it?
Conrad, M., & Angeli, J. P. F. (2015) · Molecular & Cellular Oncology · doi:10.4161/23723556.2014.995047 · Cited by 187
Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis
Verma, N., Vinik, Y., Saroha, A., Nair, N. U., Ruppin, E., Mills, G. B., Karn, T., Dubey, V., Khera, L., Raj, H., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba8968 · Cited by 184
Jin, X., Tang, J., Qiu, X., Nie, X., Ou, S., Wu, G., Zhang, R., & Zhu, J. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01825-7 · Cited by 188
Quantitative Profiling of Protein Carbonylations in Ferroptosis by an Aniline-Derived Probe
Chen, Y., Liu, Y., Lan, T., Qin, W., Zhu, Y., Qin, K., Gao, J., Wang, H., Hou, X., Chen, N., et al. (2018) · Journal of the American Chemical Society · doi:10.1021/jacs.8b01462 · Cited by 186
Dai, J., Dan, W., Schneider, U., & Wang, J. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.08.027 · Cited by 181
Shang, Y., Luo, M., Yao, F., Wang, S., Yuan, Z., & Yang, Y. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109633 · Cited by 181
Ferroptosis and ferritinophagy in diabetes complications
He, J., Li, Z., Xia, P., Shi, A., FuChen, X., Zhang, J., & Yu, P. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101470 · Cited by 187
Fluorescent probes for ferroptosis bioimaging: advances, challenges, and prospects
Yin, J., Zhan, J., Hu, Q., Huang, S., & Lin, W. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00454b · Cited by 183
Wang, X., Chen, T., Chen, S., Zhang, J., Cai, L., Liu, C., Zhang, Y., Wu, X. M., Li, N., Ma, Z., et al. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02216-9 · Cited by 188
Nanomaterial-induced ferroptosis for cancer specific therapy
Liu, M., Liu, B., Liu, Q., Du, K., Wang, Z., & He, N. (2019) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2018.12.015 · Cited by 180
Guan, X., Li, Z., Zhu, S. Y., Cheng, M., Ju, Y., Ren, L., Yang, G., & Min, D. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118660 · Cited by 180
STING1 Promotes Ferroptosis Through MFN1/2-Dependent Mitochondrial Fusion
Li, C., Liu, J., Hou, W., Kang, R., & Tang, D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.698679 · Cited by 185
Chen, Y., Wang, J., Li, J., Zhu, J., Wang, R., Xi, Q., Wu, H., Shi, T., & Chen, W. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174518 · Cited by 180
Pathological Roles of Iron in Cardiovascular Disease
Kobayashi, M., Suhara, T., Baba, Y., Kawasaki, N. K., Higa, J. K., & Matsui, T. (2018) · Current Drug Targets · doi:10.2174/1389450119666180605112235 · Cited by 182
Discovery of Novel, Drug-Like Ferroptosis Inhibitors with in Vivo Efficacy
Devisscher, L., Coillie, S. V., Hofmans, S., Rompaey, D. V., Goossens, K., Meul, E., Maes, L. J. R. M., Winter, H. L. D., der Veken, P. V., Vandenabeele, P., et al. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01299 · Cited by 183
Targeting de novo lipogenesis and the Lands cycle induces ferroptosis in KRAS-mutant lung cancer
Bartolacci, C., Andreani, C., do Vale, G. D., Berto, S., Melegari, M., Crouch, A. C., Baluya, D. L., Kemble, G. W., Hodges, K. B., Starrett, J. H., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31963-4 · Cited by 183
Cell death regulation: A new way for natural products to treat osteoporosis
Li, Z., Li, D., Chen, R., Gao, S., Xu, Z., & Li, N. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106635 · Cited by 183
Mitochondria-localized cGAS suppresses ferroptosis to promote cancer progression
Qiu, S., Zhong, X., Meng, X. L., Li, S., Qian, X., Lu, H., Cai, J., Zhang, Y., Wang, M., Ye, Z., et al. (2023) · Cell Research · doi:10.1038/s41422-023-00788-1 · Cited by 186
Shao, C., Yuan, J., Liu, Y., Qin, Y., Wang, X., Gu, J., Chen, G., Zhang, B., Liu, H., Zhao, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917946117 · Cited by 178
The p53 Tumor Suppressor in the Control of Metabolism and Ferroptosis
Gnanapradeepan, K., Basu, S., Barnoud, T., Budina-Kolomets, A., Kung, C.-P., & Murphy, M. E. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00124 · Cited by 181
Emerging Role of Ferroptosis in Acute Kidney Injury
Hu, Z., Zhang, H., Yang, S., Wu, X., He, D., Cao, K., & Zhang, W. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/8010614 · Cited by 180
Iron overload in the motor cortex induces neuronal ferroptosis following spinal cord injury
Feng, Z., Min, L., Chen, H., Deng, W., Tan, M., Liu, H., & Hou, J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101984 · Cited by 178
Hu, Q., Zuo, T., Deng, L., Chen, S., Yu, W., Liu, S., Liu, J., Wang, X., Fan, X., & Dong, Z. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154112 · Cited by 177
Ni, M., Zhou, J. N., Zhu, Z., Xu, Q., Yin, Z., Wang, Y., Zheng, Z., & Zhao, H. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154701 · Cited by 177
Lipoxygenase inhibitors protect acute lymphoblastic leukemia cells from ferroptotic cell death
Probst, L., Dächert, J., Schenk, B., & Fulda, S. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.06.112 · Cited by 178
Ou, W., Mulik, R. S., Anwar, A., McDonald, J. G., He, X., & Corbin, I. R. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.09.002 · Cited by 179
Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation
Kim, E. H., Wong, S., & Martinez, J. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0179-3 · Cited by 181
Allosteric Modulator Discovery: From Serendipity to Structure-Based Design
Lu, S., He, X., Ni, D., & Zhang, J. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01749 · Cited by 179
Angelis, M. L. D., Francescangeli, F., & Zeuner, A. (2019) · Cancers · doi:10.3390/cancers11101569 · Cited by 180
Torti, S. V., & Torti, F. M. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-2017 · Cited by 183
EF24 induces ferroptosis in osteosarcoma cells through HMOX1
Lin, H., Chen, X., Zhang, C., Yang, T., Deng, Z., Song, Y., Huang, L. J., Li, F., Li, Q., Lin, S., et al. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111202 · Cited by 176
Zhao, T., Guo, X., & Sun, Y. (2021) · Aging and Disease · doi:10.14336/ad.2020.0912 · Cited by 180
Zhang, X., Yu, K., Ma, L., Qian, Z., Tian, X., Miao, Y., Niu, Y., Xu, X., Guo, S., Yang, Y., et al. (2021) · Theranostics · doi:10.7150/thno.55482 · Cited by 176
Lu, Y., Qin, H., Jiang, B., Lu, W., Hao, J., Cao, W., Du, L., Chen, W., Zhao, X., & Guo, H. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.09.014 · Cited by 178
PPARα alleviates iron overload‐induced ferroptosis in mouse liver
Xing, G., Meng, L., Cao, S., Liu, S., Wu, J., Li, Q., Huang, W., & Zhang, L. (2022) · EMBO Reports · doi:10.15252/embr.202052280 · Cited by 179
HMGB1 regulates erastin-induced ferroptosis via RAS-JNK/p38 signaling in HL-60/NRASQ61L cells.
Ye, F., Chai, W., Xie, M., Yang, M., Yan, Y., Cao, L., & Yang, L. (2019) · PubMed Central · Cited by 174
Ren, J., Li, C., Yan, X., Qu, Y., Yang, Y., & Guo, Z. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6643382 · Cited by 176
The molecular mechanisms of ferroptosis and its role in cardiovascular disease
Zhang, Y., Xin, L., Xiang, M., Shang, C., Wang, Y., Wang, Y., Cui, X., & Lu, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112423 · Cited by 175
Bao, W., Zhou, X., Zhou, L., Wang, F., Yin, X., Lu, Y., Zhu, L., & Liu, D. (2020) · Aging Cell · doi:10.1111/acel.13235 · Cited by 175
NCOA4-mediated ferritinophagy promotes ferroptosis induced by erastin, but not by RSL3 in HeLa cells
Gryzik, M., Asperti, M., Denardo, A., Arosio, P., & Poli, M. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118913 · Cited by 177
The emerging roles of MAPK-AMPK in ferroptosis regulatory network
Wang, X., Tan, X., Zhang, J., Wu, J., & Shi, H. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01170-9 · Cited by 178
Yu, X., & Long, Y. C. (2016) · Scientific Reports · doi:10.1038/srep30033 · Cited by 176
Iron and leukemia: new insights for future treatments
Wang, F., Lv, H., Zhao, B., Zhou, L., Wang, S., Luo, J., Liu, J., & Shang, P. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1397-3 · Cited by 172
Cigarette smoke extract induces ferroptosis in vascular smooth muscle cells
Sampilvanjil, A., Karasawa, T., Yamada, N., Komada, T., Higashi, T., Baatarjav, C., Watanabe, S., Kamata, R., Ohno, N., & Takahashi, M. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00559.2019 · Cited by 174
ACSL4 is a predictive biomarker of sorafenib sensitivity in hepatocellular carcinoma
Ji, F., Lu, P.-Z., Zhu, G., Hooi, S. C., Wu, Y., Huang, X., Dai, H.-Q., Chen, P.-H., Li, Z., Su, W., et al. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0439-x · Cited by 170
Non-coding RNAs and ferroptosis: potential implications for cancer therapy
Balihodzic, A., Prinz, F., Dengler, M. A., Călin, G. A., Jost, P. J., & Pichler, M. (2022) · Cell Death and Differentiation · doi:10.1038/s41418-022-00998-x · Cited by 175
Fan, Z., Yang, G., Zhang, W., Liu, Q., Liu, G., Liu, P., Xu, L., Wang, J., Yan, Z., Han, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16957 · Cited by 170
A “Closed‐Loop” Therapeutic Strategy Based on Mutually Reinforced Ferroptosis and Immunotherapy
Du, Y., Zhang, R., Yang, J., Liu, S., Zhou, J., Zhao, R., He, F., Zhang, Y., Yang, P., & Lin, J. (2022) · Advanced Functional Materials · doi:10.1002/adfm.202111784 · Cited by 169
Exploiting ferroptosis vulnerabilities in cancer
Nakamura, T., & Conrad, M. (2024) · Nature Cell Biology · doi:10.1038/s41556-024-01425-8 · Cited by 172
Deubiquitinases Maintain Protein Homeostasis and Survival of Cancer Cells upon Glutathione Depletion
Harris, I. S., Endress, J. E., Coloff, J. L., Selfors, L. M., McBrayer, S. K., Rosenbluth, J. M., Takahashi, N., Dhakal, S., Koduri, V., Oser, M. G., et al. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.020 · Cited by 171
Sha, R., Xu, Y., Yuan, C., Sheng, X., Wu, Z., Peng, J., Wang, Y., Lin, Y., Zhou, L., Xu, S., et al. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103560 · Cited by 171
Chen, H., Qi, Q., Wu, N., Wang, Y., Feng, Q., Jin, R., & Jiang, L. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102426 · Cited by 168
Lin, Z., Liu, Y., Xue, N., Zheng, R., Yan, Y., Wang, Z., Li, Y., Ying, C.-Z., Song, Z., Tian, J., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7769355 · Cited by 173
Dai, W., Shu, R., Yang, F., Li, B., Johnson, H. M., Yu, S., Yang, H., Chan, Y. K., Yang, W., Bai, D., et al. (2023) · Advanced Materials · doi:10.1002/adma.202305277 · Cited by 168
Self-citationZhou, S., Liu, J., Wan, A., Zhang, Y., & Qi, X. (2024) · Journal of Hematology & Oncology · doi:10.1186/s13045-024-01545-6 · Cited by 175
Cancer stem cell regulated phenotypic plasticity protects metastasized cancer cells from ferroptosis
Wu, M., Zhang, X., Zhang, W., Chiou, Y., Qian, W., Liu, X., Zhang, M., Yan, H., Li, S., Li, T., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29018-9 · Cited by 172
Reed, A., Ichu, T.-A., Milosevich, N., Melillo, B. N., Schafroth, M. A., Otsuka, Y., Scampavia, L. D., Spicer, T., & Cravatt, B. F. (2022) · ACS Chemical Biology · doi:10.1021/acschembio.2c00317 · Cited by 169
Cui, S., Ghai, A., Deng, Y., Li, S., Zhang, R., Egbulefu, C., Liang, G., Achilefu, S., & Ye, J. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.09.025 · Cited by 168
Ferroptotic stress promotes macrophages against intracellular bacteria
Ma, R., Fang, L., Chen, L., Wang, X., Jiang, J., & Gao, L. (2022) · Theranostics · doi:10.7150/thno.66663 · Cited by 167
Ferroptosis in Cancer Progression: Role of Noncoding RNAs
Zuo, Y.-B., Zhang, Y., Zhang, R., Tian, J., Lv, X., Li, R., Li, S., Cheng, M.-D., Shan, J., Zhao, Z., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.66917 · Cited by 171
The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection
Ravíngerová, T., Kindernay, L., Barteková, M., Ferko, M., Adameová, A., Zohdi, V., Bernátová, I., Ferenczyová, K., & Lazou, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217889 · Cited by 169
Posttranslational Modifications in Ferroptosis
Wei, X., Yi, X., Zhu, X., & Jiang, D. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8832043 · Cited by 165
Autophagy, Pyroptosis, and Ferroptosis: New Regulatory Mechanisms for Atherosclerosis
Lin, L., Zhang, M.-X., Zhang, L., Zhang, D., Li, C., & Li, Y. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.809955 · Cited by 166
CircBCAR3 accelerates esophageal cancer tumorigenesis and metastasis via sponging miR-27a-3p
Xi, Y., Shen, Y., Wu, D., Zhang, J., Lin, C., Wang, L., Yu, C., Yu, B., & Shen, W. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01615-8 · Cited by 167
Mitochondria reactive oxygen species signaling in immune responses
Weinberg, S. E., & Chandel, N. S. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.012 · Cited by 175
Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
Shi, T., & Dansen, T. B. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8074 · Cited by 173
Inhibition of ACSL4 attenuates ferroptotic damage after pulmonary ischemia‐reperfusion
Xu, Y., Li, X., Cheng, Y., Yang, M., & Wang, R. (2020) · The FASEB Journal · doi:10.1096/fj.202001758r · Cited by 166
Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications
Zheng, H., Jiang, J., Xu, S., Liu, W., Xie, Q., Cai, X., Zhang, J., Liu, S., & Li, R. (2021) · Nanoscale · doi:10.1039/d0nr08478f · Cited by 167
GLS2 Is a Tumor Suppressor and a Regulator of Ferroptosis in Hepatocellular Carcinoma
Suzuki, S., Venkatesh, D., Kanda, H., Nakayama, A., Hosokawa, H., Lee, E., Miki, T., Stockwell, B. R., Yokote, K., Tanaka, T., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-3914 · Cited by 168
Self-citationMitochondrial event as an ultimate step in ferroptosis
Oh, S. J., Ikeda, M., Ide, T., Hur, K. Y., & Lee, M. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01199-8 · Cited by 167
Cell cycle arrest induces lipid droplet formation and confers ferroptosis resistance
Lee, H., Horbath, A. D., Kondiparthi, L., Meena, J. K., Lei, G., Dasgupta, S., Liu, X., Zhuang, L., Koppula, P., Li, M., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44412-7 · Cited by 188
Chen, B., Chen, Z., Liu, M., Gao, X., Cheng, Y., Wei, Y., Wu, Z. B., Cui, D., & Shang, H. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.08.013 · Cited by 164
Sang, M., Luo, R., Bai, Y., Dou, J., Zhang, Z., Liu, F., Feng, F., Xu, J., & Liu, W. (2019) · Theranostics · doi:10.7150/thno.36283 · Cited by 163
Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4
Wang, S., Liu, W., Wang, J., & Bai, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118356 · Cited by 164
Ferroptosis: regulation by competition between NRF2 and BACH1 and propagation of the death signal
Nishizawa, H., Yamanaka, M., & Igarashi, K. (2022) · FEBS Journal · doi:10.1111/febs.16382 · Cited by 164
Identification of a targeted ACSL4 inhibitor to treat ferroptosis-related diseases
Huang, Q. W., Ru, Y., Luo, Y., Luo, X., Liu, D., Ma, Y., Zhou, X., Linghu, M., Xu, W., Gao, F., et al. (2024) · Science Advances · doi:10.1126/sciadv.adk1200 · Cited by 165
Brigelius‐Flohé, R., & Flohé, L. (2016) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2016.08.003 · Cited by 162
Metabolic Control by Heat Stress Determining Cell Fate to Ferroptosis for Effective Cancer Therapy
Xie, S., Sun, W., Zhang, C., Dong, B., Yang, J., Hou, M., Xiong, L., Cai, B., Liu, X., & Xue, W. (2021) · ACS Nano · doi:10.1021/acsnano.1c00380 · Cited by 163
Kong, R., Wang, N., Han, W., Bao, W., & Lu, J. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ma1220-815rrr · Cited by 164
Iron, ferroptosis, and ischemic stroke
Guo, J., Tuo, Q., & Lei, P. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15807 · Cited by 163
A MOF-Based Potent Ferroptosis Inducer for Enhanced Radiotherapy of Triple Negative Breast Cancer
Zeng, L., Ding, S., Cao, Y., Li, C., Zhao, B., Ma, Z., Zhou, J., Hu, Y., Zhang, X., Yang, Y., et al. (2023) · ACS Nano · doi:10.1021/acsnano.3c00048 · Cited by 163
Metadata
- Authors
- Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., Brown, L. M., Girotti, A. W., Cornish, V. W., Schreiber, S. L., & Stockwell, B. R.
- Affiliations
- Columbia University (US)
- Broad Institute (US)
- Medical College of Wisconsin (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Stockwell, Brent R.
- ORCID
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2014-01
- Volume
- 156
- Issue
- 1-2
- Pages
- 317-331
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC4076414
- OpenAlex
- W2002490399
- Cited by
- 7,713
- References
- 48
- Citations by year
- 2026: 1070 · 2025: 1226 · 2024: 1343 · 2023: 1164 · 2022: 1041 · 2021: 759 · 2020: 421 · 2019: 256 · 2018: 151 · 2017: 115 · 2016: 86 · 2015: 53 · 2014: 25
- FWCI
- 74.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation (CHE 0840451)
- New York State Stem Cell Science (C026715)
- Empire State Development's Division of Science, Technology and Innovation
- Arnold and Mabel Beckman Foundation
- National Institutes of Health (R01CA161061, 5R01CA097061, 5R01GM085081, 1S10RR025431-01A1)
- Broad Institute
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- ferroptosis, GPX4, glutathione peroxidase, glutathione depletion, ferroptosis inducers, non-apoptotic cell death, cancer cell death, chemoproteomics, targeted metabolomics, diffuse large B-cell lymphoma, renal cell carcinoma, tumor growth inhibition
- MeSH terms
- Phospholipid Hydroperoxide Glutathione Peroxidase, Animals, Carbolines, Carcinoma, Renal Cell, Glutathione, Glutathione Peroxidase, Humans, Neoplasm Transplantation, Neoplasms, Piperazines, Lymphoma, B-Cell, Cell Death, Cell Line, Tumor, Mice, Gene Knockdown Techniques, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
